Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.
∙ DISEASE CHARACTERISTICS:
• Meets one of the following criteria:
‣ Histologically confirmed solid tumor or hematologic malignancy
⁃ Awaiting biopsy or surgery for cancer evaluation of a mass detected on exam or standard imaging
∙ PATIENT CHARACTERISTICS:
• Able to lie still in the PET scanner
• Girth and weight must be suitable to enter the gantry
• Not pregnant or nursing
• Negative pregnancy test
• Fertile patients must use effective contraception
∙ PRIOR CONCURRENT THERAPY:
• Not specified